How many stocks fighting COVID-19 have maintained their momentum?

While COVID-19 has been an overall negative for most companies, others have benefited.

Featuring heavily on our top 50 stocks for February and March were a small cap contingent of potential coronavirus fighters, including any company that mentioned ‘hand sanitiser’.

It was a broad list of stocks including tele-health plays, hand sanitiser manufacturers, tech stocks winning government contracts and biotechs testing their drugs against the virus.

As of right now, a portfolio of all these stocks would have returned 137 per cent in the last 12 months and 43 per cent in the last 6.

But the overall numbers of winners and losers are almost dead level, and only 7 of the 25 stocks on our list have seen gains of over 100 per cent over the past year.

Code	Name	Price (I)	1Y Tot Ret	6M Tot Ret	Market Cap
ZNO	ZOONO GROUP LTD	2.97	2910	389	$510.5M
PAA	PHARMAUST LTD	0.2	300	117	$66.1M
HT8	HARRIS TECHNOLOGY GROUP LTD	0.035	192	289	$6.8M
MSB	MESOBLAST LTD	3.36	132	52	$2.1B
WSP	WHISPIR LTD	3.35	125	125	$334.3M
AEI	AERIS ENVIRONMENTAL LTD	0.685	118	153	$163.7M
GSS	GENETIC SIGNATURES LTD	2.33	116	140	$335.1M
UCM	USCOM LTD	0.215	63	76	$41.2M
BIT	BIOTRON LTD	0.1	19	79	$72.7M
HCT	HOLISTA COLLTECH LTD	0.061	14	-9	$21.8M
IHL	INCANNEX HEALTHCARE LTD	0.07	0	15	$52.8M
ESE	ESENSE-LAB LTD-CDI	0.019	0	67	$10.2M
DEM	DE.MEM LTD	0.16	-6	-33	$28.1M
GTG	GENETIC TECHNOLOGIES LTD	0.006	-16	-45	$45.1M
BKL	BLACKMORES LTD	72.35	-19	-17	$1.4B
ADR	ADHERIUM LTD	0.022	-22	-32	$15.0M
FOD	FOOD REVOLUTION GROUP LTD/TH	0.054	-37	-31	$39.1M
JAT	JATENERGY LTD	0.035	-38	-35	$33.6M
MX1	MICRO-X LTD	0.155	-39	-7	$53.6M
WNB	WELLNESS AND BEAUTY SOLUTION	0.007	-46	-22	$9.2M
LSH	LIFESPOT HEALTH LTD	0.038	-53	36	$3.9M
MPH	MEDILAND PHARM LTD	0.125	-59	-55	$39.1M
1ST	1ST GROUP LTD	0.03	-68	-60	$13.2M
NET	NETLINKZ LTD	0.058	-79	-45	$118.1M
ONE	ONEVIEW HEALTHCARE PLC-CDI	0.044	-82	-63	$8.1M

The Magnificent Seven

The biggest gainer is hand sanitiser maker Zoono (ASX:ZNO), up nearly 3000 per cent in a year.

Zoono and its peer Holista Colltech (ASX:HCT) both reported exponential demand for their hand sanitisers as COVID-19 broke out initially in Asia.

Holista, however, is only up 14 per cent on a yearly basis and has retreated in recent days after encountering supply chain issues.

Coming in at 2nd and 4th are two biotechs looking to fight the virus head on in Mesoblast (ASX:MSB) (+132%) and PharmAust (ASX:PAA) (+300%).

Mesoblast is the world’s biggest listed stem-cell play, but it is testing its treatment on acute respiratory distress syndrome (Ards), the largest cause of death with COVID-19.

This is in addition to stem-cell clinical trials on chronic heart failure and lower back pain — both of which are expected this quarter.

PharmAust is trialling its cancer-fighting monepantel drug against COVID-19. For both diseases, it inhibits a signalling pathway into the cell cycle.

Another biotech on the list is Genetic Signatures (ASX:GSS) (+116%) which developed its own COVID-19 test that is approved in Australia and Europe.

Harris Technology (ASX:HT8) (+192%) was already an online shopping operator, but in April it took the step of launching protective hygiene products including face masks, alcohol wipes and hand sanitisers.

Rounding out the list were clean tech Aeris Environmental (ASX:AEI) (+118%) which has been providing hygiene products and communication automation software stock Whispir (ASX:WSP) (+125%) which has won several public sector contracts during the pandemic.